The Annual General Meeting 2023 of BioNTech SE will be held at its premises, An der Goldgrube 12, 55131 Mainz, Germany, on 25 May 2023 with the physical presence of the shareholders or their authorised representatives.
Video and audio transmission of the Annual General Meeting
All shareholders of the Company, holders of the Company’s American Depositary Shares (ADS) and interested members of the public will be able to follow the introductory remarks of the Chairman of the Meeting and the subsequent speeches of the Chief Executive Officer and the Chief Financial Officer at the Annual General Meeting on Thursday, 25 May 2023, from 14:00h (CEST) via this page.
Investor Portal der BioNTech SE
Following proper registration in accordance with Section III. 2 of the Invitation of the Annual General Meeting, shareholders entered in the share register may attend the Annual General Meeting and exercise their voting rights there in person. However, they may also exercise their voting rights by authorised representatives or by proxies appointed by the Company or by way of electronic voting via the Investor Portal.
Shareholders and their proxies may register for the Annual General Meeting, grant powers of attorney with instructions to the proxies appointed by the Company and powers of attorney to other authorised representatives and cast their votes on the resolutions of the Annual General Meeting, without attending the Annual General Meeting, by electronic postal vote until 24:00h (CEST) on Wednesday, 24 May 2023:
Please note the closing date of 24:00h (CEST) on Wednesday, 18 May 2023.
For further details on, among other things, how shareholders can exercise their voting rights and ask questions, please refer to section "III. Further Information" of the Invitation of the Annual General Meeting.
Holders of ADSs issued by The Bank of New York Mellon (BNYM) should contact BNYM or their broker bank for voting information.
Additional information is also available here.
